Fintel reports that on January 21, 2025, TD Cowen initiated coverage of Forte Biosciences (NasdaqCM:FBRX) with a Buy ...

Kimberly-Clark Corp (KMB) stock saw a modest uptick, ending the day at $127.22 which represents a slight increase of $0.57 or 0.45% from the prior close of $126.65. The stock opened at $126.77 and ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.31% of ...

Elevated rates in LTL are starting to crack, driven by less discipline in fuel surcharges, according to a market report. LTL ...

There’s Donald Trump the crypto champion, promising to unshackle an industry hit by a years-long regulatory crackdown. Then ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

TD Cowen analyst Brendan Smith maintained a Buy rating on Ginkgo Bioworks Holdings (DNA – Research Report) today and set a price target of $10.00. The company’s shares closed yesterday at $8.86.

In a report released today, Lance Vitanza from TD Cowen reiterated a Buy rating on Compass Diversified Holdings (CODI – Research Report), with ...

Pembina Pipeline (NYSE:PBA) +0.5% in Wednesday's trading as analysts at TD Cowen call the stock its top pick for Canadian ...

Investing.com -- TD Cowen managing director Jaret Seiberg raised concerns that the recent issuance of a Donald Trump meme coin could pose challenges to bipartisan efforts to pass cryptocurrency market ...

Salesforce has been upgraded to a Buy from TD Cowen analysts, who also raised their price target to $400 per share citing the year-end stock rally tied to the deployment of the Agentforce AI product.